Professor Sarah Larney
Co-Head, Alcohol and Other Drugs
Working groups
Background
Professor Sarah Larney's research focuses on the epidemiology and prevention of drug-related harms, particularly blood-borne viral infections and overdose. Prior to her appointment as co-head of the Alcohol and Other Drugs working group at Burnet, she was an Associate Professor in the Department of Family Medicine and Emergency Medicine at the Université de Montréal and Principal Researcher at the Centre de recherche du Centre hospitalier de l'Université de Montréal.
Sarah's contributions to the field include findings related to drug use and treatment of opioid dependence among older adults; work documenting the onset of Canada's overdose epidemic in Québec (delayed relative to the rest of Canada); and novel findings relating to sex and gender differences in hepatitis C among people who inject drugs. Her work has influenced opioid treatment delivery in Australia, the United States and Canada.
Qualifications
- 2011: PhD, University of New South Wales, Australia
- 2003: Bachelor of Arts/Bachelor of Science (Honours), University of New South Wales, Australia
Burnet publications
View 3 moreThe association between chronic pain and non‐fatal overdose in people who inject drugs: Longitudinal cohort study in Montreal, Canada, 2017 to 2025
Addiction
Sarah Larney et al
Methadone vs Buprenorphine-Naloxone in Opioid Overdose Survivors
JAMA Network Open
Robert A. Kleinman et al
Claims to crisis: Rethinking opioid overdose in Canada
International Journal of Drug Policy
Sarah Larney, Kari Lancaster
Current projects
Unlocking health: using linked administrative data to improve health outcomes for people incarcerated in Victoria
In this project we aim to establish a system for monitoring health and health service use among people leaving prison in Victoria.
Substance use support for women moving in and out of prison (SUSTain)
We’re delivering alcohol and other drugs transitional care for women leaving prison – codesigned with those who know it best.